Eight leading academic centres, including the Cambridge Institute for Public Health (CIPH), are to begin a collaboration that will play a key role in increasing the evidence base for effective public health practice.
Researchers have identified 10 different types of the disease, laying groundwork for more effective, targeted treatment plans.
A new Regius Professor of Physic at the ̽»¨Ö±²¥ of Cambridge has been approved by Her Majesty ̽»¨Ö±²¥Queen to succeed Professor Sir Patrick Sissons who will retire on 30 September 2012.
New discoveries by Cambridge scientists about a molecular waste-disposal process that ‘eats’ bacteria are influencing the clinical management of cystic fibrosis, and could be the basis of innovative new treatments to fight off bacteria.
Study suggests that anti-inflammatory drugs could be used to treat cardiovascular disease.
Patient information reveals women, young people, ethnic minorities and people with less common cancers have the highest number of pre-referral consultations.
A collaborative project between physicists, oncologists and computer scientists at Oxford and Cambridge Universities, launched last month, will develop improved tools for the planning of high precision radiotherapy. Accel-RT will also help overcome time constraints that currently limit the use of complex radiotherapy treatment.
Researchers have discovered how receptors for the female sex hormone oestrogen attach to a different part of the DNA in breast cancer patients who are more likely to relapse.
Six members of the ̽»¨Ö±²¥ have been recognised in the Queen’s New Year Honours list.
A collaboration between virologists and neuroscientists at Cambridge ̽»¨Ö±²¥ has demonstrated how viruses that cross the blood/brain barrier could be exploited to slow down, or even halt, the progress of Parkinson’s and other neurodegenerative diseases.
© 2025 ̽»¨Ö±²¥ of Cambridge